Sponsor of the Day:
Jerkmate
https://protalix.com/procellex-platform
ProCellEx®Platform | Protalix
ProCellEx® is our proprietary platform used to produce and manufacture recombinant proteins through plant cell-based expression systems. Our platform is a...
protalix
https://protalix.com/privacy-policy
Privacy Policy | Protalix
privacy policyprotalix
https://protalix.com/products/elelyso
Elelyso® | Protalix
Elelyso® (taliglucerase alfa) is an Enzyme Replacement Therapy (ERT), replacing the deficient glucocerebrosidase enzyme with a recombinant form of the protein....
protalix
https://protalix.com/from-concept-to-market
From concept to market | Protalix
Protalix is harnessing the power of cultivated plant cells to express biologically enhanced therapeutic proteins to tackle unmet needs for rare diseases....
conceptmarketprotalix
https://www.chiesi.com/it/media-hub/comunicati-stampa/elfabrio-approvazione-commissione-europea-somministrazione-quattro-settimane
Chiesi Global Rare Diseases e Protalix BioTherapeutics
Il regime approvato riduce il carico terapeutico per i pazienti idonei, le loro famiglie e il sistema sanitario, estendendo l’intervallo tra le infusioni
global rarechiesidiseasesprotalixbiotherapeutics
https://protalix.com/products/elfabrio
Elfabrio® | Protalix
Elfabrio® (pegunigalsidase alfa) is an Enzyme Replacement Therapy (or ERT), replacing the deficient α-galactosidase-A enzyme with a recombinant form of the...
protalix